10 Best Warren Buffett Stocks To Watch Right Now

Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company’s economic output. That’s because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.

Earnings’ unreliability is one of the reasons Foolish investors often flip straight past the income statement to check the cash flow statement. In general, by taking a close look at the cash moving in and out of the business, you can better understand whether the last batch of earnings brought money into the company, or merely disguised a cash gusher with a pretty headline.

Calling all cash flows
When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on AAR (NYSE: AIR  ) , whose recent revenue and earnings are plotted below.

10 Best Warren Buffett Stocks To Watch Right Now: CRB Futures Index(CR)

Crane Co. manufactures and sells engineered industrial products in the United States and internationally. The company operates in five segments: Aerospace & Electronics, Engineered Materials, Merchandising Systems, Fluid Handling, and Controls. The Aerospace & Electronics segment offers pressure, fuel flow, and position sensors and subsystems; brake control systems; coolant, lube and fuel pumps; and seat actuation products. This segment also provides power supplies and custom microelectronics for aerospace, defense, medical, and other applications; and electrical power components, power management products, electronic radio frequency, and microwave frequency components and subsystems for the defense, space, and military communications markets. The Engineered Materials segment manufactures fiberglass-reinforced plastic panels for the truck trailer and recreational vehicle markets, industrial markets, and the commercial construction industry. The Merchandising Systems segmen t offers vending solutions, such as food, snack, and beverage vending machines; and vending machine software and online solutions, as well as payment solutions, including coin accepters and dispensers, coin hoppers, coin recyclers, bill validators, and bill recyclers. The Fluid Handling segment manufactures and sells various industrial and commercial valves and actuators; provides valve testing, parts, and services; manufactures and sells pumps and water purification solutions; distributes pipe, pipe fittings, couplings, and connectors; and designs, manufactures, and sells corrosion-resistant plastic-lined pipes and fittings. The Controls segment produces ride-leveling, air-suspension control valves for heavy trucks and trailers; pressure, temperature, and level sensors; ultra-rugged computers, measurement and control systems, and intelligent data acquisition products; and water treatment equipment. Crane Co. was founded in 1855 and is based in Stamford, Connecticut.

Advisors’ Opinion:

  • [By Chuck Carnevale]

    Next, I run graphs on liquidity ratios and additional data on various valuation ratios to include price to book value (pb), price to cash flow (pcfl), price to free cash flow (pfcfl) and others that can be seen as options on the navigation bar to the left of the sample graph which only plots the current ratio (cr), a quick ratio (qr) and for those diehards concerned with volatility [size=11.0pt;line-height:115%; font-family:”Calibri”,”sans-serif”;mso-ascii-theme-font:minor-latin;mso-fareast-font-family: Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin; mso-bidi-font-family:”Times New Roman”;mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA”>—

  • [By Seth Jayson]

    Basic guidelines
    In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven’t materialized. Is the current inventory situation at Crane (NYSE: CR  ) out of line? To figure that out, start by comparing the company’s inventory growth to sales growth. How is Crane doing by this quick checkup? At first glance, OK, it seems. Trailing-12-month revenue increased 0.6%, and inventory decreased 2.4%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue dropped 2.8%, and inventory contracted 2.4%. Over the sequential quarterly period, the trend looks OK but not great. Revenue dropped 0.4%, and inventory grew 2.0%.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Crane (NYSE: CR  ) , whose recent revenue and earnings are plotted below.

10 Best Warren Buffett Stocks To Watch Right Now: Centor Energy Inc (CNTO)

Centor Energy Inc, formerly Centor, Inc., incorporated on February 16, 2011, is an exploration-stage company. The Company is engaged in the business of mineral exploration.

On November 26, 2012, the Company entered into a purchase agreement with Bullnet Gold Resources Limited. As of May 31, 2013, the Company had not generated revenues. As of May 31, 2013, the Company had no mining operations.

Advisors’ Opinion:

  • [By John Udovich]

    Many American oil and gas investors are probably familiar with the major large and small cap players in the Bakken formation in North Dakota and Montana, but few American investors are probably familiar with the active players further to the north in the oil and gas rich Canadian provinces of Saskatchewan and Alberta with small cap stocks like Alexander Energy Ltd (CVE: ALX), Renegade Petroleum Ltd (CVE: RPL) and Centor Energy Inc (OTCBB: CNTO) along with large cap Suncor Energy Inc (NYSE: SU) being among those pumping out their share of noteworthy news lately. I should point out that Canada’s oil reserves are ranked #3 after to Venezuela and Saudi Arabia with over 95% of these reserves being the controversial oil sands of Alberta while the neighboring province of Saskatchewan (which the Bakken formation actually stretches into) along with offshore areas of Newfoundland also containing substantial production and reserves. Moreover and excluding the oil sands, Alber ta would have 39% of Canada’s remaining conventional oil reserves, followed by offshore Newfoundland with 28% and Saskatchewan with 27%.

  • [By James E. Brumley]

    Well, that answers that question. Questerre Energy Corp. (TSE:QEC) and Crescent Point Energy Corp. (TSE:CPG) likely knew they had some shale-oil mining neighbors in the Bakken Shale neighborhood in Saskatchewan, Canada, but they hadn’t seen much of that competition. That’s about to change soon. Adequately funded and eager to begin laying its final mining plans, Centor Energy Inc. (OTCBB:CNTO) is going to officially own 55% of a 21,000 acre shale oil property that’s anywhere from just a few miles away to just a few meters away from and Crescent Point Energy’s and Questerre Energy’s operations in one of the oil-richest known areas in the Bakken formation. And to be clear, it’s not like Centor Energy is just getting the ball rolling; the planning for this project has been underway for months. Once the property-acquisition deal is inked in mid-February, CNTO will likely finish up its feasibility study and begin the approval process for its facility later in the year. That’s pr etty quick, but as was noted, a great deal of the legwork has already been done.

  • [By John Udovich]

    While the Bakken formation is already on most investor radars, few American investors may realize that the formation stretches North into the oil and gas rich Canadian province of Saskatchewan where stocks like Surge Energy Inc (TSE: SGY), Questerre Energy Corp (TSE: QEC), Crescent Point Energy Corp (TSE: CPG), Keyera Corp (TSE: KEY) and Centor Energy Inc (OTCBB: CNTO) have been pumping out a good flow of newsworthy news in recent weeks. I should mention that Canada’s oil reserves are ranked #3 after to Venezuela and Saudi Arabia with over 95% of these reserves being the oil sands of Alberta while the neighboring province of Saskatchewan (which the Bakken formation stretches into from South Dakota and Montana) along with offshore areas of Newfoundland also contain substantial production and reserves (Note: Excluding oil sands, Alberta would have 39% of Canada’s remaining conventional oil reserves, followed by offshore Newfoundland with 28% and Saskatchewan with 2 7%).

10 Best Warren Buffett Stocks To Watch Right Now: Imperial Holdings Inc. (IFT)

Imperial Holdings, Inc., through its subsidiaries, operates as a specialty finance company in the United States. The company operates in two business segments: Life Finance and Structured Settlements. The Life Finance segment comprises life settlements and finance loan businesses. The Structured Settlement segment purchases structured settlements at a discounted rate and sells such assets to third parties. This segment primarily markets its products through the Internet and television. Imperial Holdings, Inc. was founded in 2006 and is based in Boca Raton, Florida.

Advisors’ Opinion:

  • [By Whopper Investments]

    Note: This is my response to the recent short case on Imperial Finance (IFT). Obviously, all humans are fallible, and I’m sure someone can find just as much to argue with my long case as I found to argue with his short case. Please read for yourself, do your own research, and make your own decision. I am long IFT and plan on fully participating in the rights offering.

10 Best Warren Buffett Stocks To Watch Right Now: Morgan Stanley Technology Etf (MTK)

SPDR Morgan Stanley Technology (ETF) (the Fund), formerly Morgan Stanley Technology ETF, seeks to replicate as closely as possible the performance of the Morgan Stanley Technology Index (the Index). The Fund utilizes a passive or indexing approach and attempts to approximate the investment performance of its benchmark Index, by investing in a portfolio of stocks intended to replicate the index.

The Fund’s industry breakdown includes communications equipment, software, computers and peripherals, semiconductors and semiconductor equipment, information technology (IT) services, Internet software and services, Internet and catalog retail, and electronic equipment and instruments. The Fund’s portfolio includes AMAZON.COM, INC, FIRST DATA CORP., JUNIPER NETWORKS, INC., APPLE, INC. and EMC CORP.

Advisors’ Opinion:

  • [By Selena Maranjian]

    Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you’d like to add some tech-heavy stocks to your portfolio, but don’t have the time or expertise to hand-pick a few, the SPDR Morgan Stanley Technology ETF (NYSEMKT: MTK  ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this technology ETF to invest in lots of them simultaneously.

    The basics
    ETFs often sport lower expense ratios than their mutual fund cousins. The technology ETF’s expense ratio — its annual fee — is a relatively low 0.50%. The fund is fairly small, too, so if you’re thinking of buying, beware of possibly large spreads between its bid and ask prices. Consider using a limit order if you want to buy in.

10 Best Warren Buffett Stocks To Watch Right Now: Pimco High Income Fund(PHK)

PIMCO High Income Fund is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Company LLC. It invests in the public fixed income markets across the globe. The fund invests in U.S. dollar denominated high-yield corporate debt obligations. It employs fundamental analysis along with a top down stock picking approach to make its investments. PIMCO High Income Fund was formed on April 30, 2003 and is domiciled in the United States.

Advisors’ Opinion:

  • [By Dan Caplinger]

    But you can see in several places the consequences of the stampede toward high yield. Here are just a few:

    Closed-end funds Cornerstone Progressive (NYSEMKT: CFP  ) and Pimco High Income (NYSE: PHK  ) both make fixed payments back to fund shareholders on a monthly basis, and their distribution yields are truly extraordinary, at about 17% and 12%, respectively. Those dividends have enticed shareholders to pay $1.30 to $1.40 or more for each $1 of assets in the funds. Yet during most months, a substantial portion of those distribution payments has simply been a return of investor capital rather than true income from the funds’ investments. A recent study discussed in The Wall Street Journal found that returns on a portfolio with a combined value and dividend-income strategy outperformed a strategy focused more exclusively on maximizing dividends by an average of 1.7 percentage points per year, a huge edge in long-run returns. In the dividend ETF arena, most funds tend to focus on maximizing yield. Although the popular Vanguard Dividend Appreciation (NYSEMKT: VIG  ) ETF bucks the trend by screening first for consistent dividend growth and only then looking at yield as a factor, many rival ETFs start with high-yielding stocks as their baseline and only then consider other desirable traits. Others focus solely on high-dividend niches of the market, such as iShares FTSE NAREIT Mortgage-Plus (NYSEMKT: REM  ) and its concentration on high-yield mortgage REITs.

    When dividend stocks get too popular, their prices get out of line with both their dividend income and the fundamentals of the businesses that underlie those stocks. In simpler terms, when dividend stocks become bad values, it’s time to consider looking elsewhere for a margin of safety.

  • [By Dan Caplinger]

    Lesson 1: Income is king.
    A look at the four funds trading at the highest premiums to net asset value reveals a common thread: They’re all focused on maximizing income. What’s interesting, though, is that they use different methods to reach the same ends. Among the three PIMCO funds, PIMCO High Income (NYSE: PHK  ) looks largely to the high-yield bond market for its holdings, while PIMCO Corporate & Income Opportunities (NYSE: PTY  ) has a somewhat lower distribution rate but has a sizable allocation to investment-grade debt. The fund with the highest premium, PIMCO Global StocksPLUS, uses futures contracts to add stock exposure to its portfolio of income-producing bonds. Finally, BlackRock Virginia Municipal Bond rounds out the top four with its tax-free bond portfolio.

  • [By Morgan Housel]

    Interest rates have risen over the last month, offering a taste. Pimco High Income Fund (NYSE: PHK  ) is down 10% in the last month. The Vanguard Long Term Corporate Bond Fund (NASDAQ: VCLT  ) lost 4.6%. Mortgage REITS sensitive to the same interest rate risk have been pummeled; Annaly Capital Management (NYSE: NLY  ) shares are off by one-fifth over the last year.

10 Best Warren Buffett Stocks To Watch Right Now: Guggenheim S&P 500 Pure Growth ETF (RPG)

Rydex S&P 500 Pure Growth ETF (the Fund) seeks to replicate as closely as possible the performance of the S&P 500/Citigroup Pure Growth Index (the Index). The S Index is narrow in focus, containing only those S&P 500 companies with strong growth characteristics as selected by Standard & Poor’s. The Index contains approximately one-third of the equities of the S&P 500 Index.

The Fund uses a passive management strategy to track the performance of the Index. The Fund invests in substantially all of the securities in the Index in approximately the same proportions as in the Index. The Fund’s investment advisor is Rydex Investments.

Advisors’ Opinion:

  • [By John Udovich]

    Yesterday, small cap geothermal stock U.S. Geothermal Inc (NYSEMKT: HTM) produced a geyser of a return when it surged 26.79%, meaning its worth taking a closer look at the stock verses the performance of other geothermal stocks like small cap Ormat Technologies, Inc (NYSE: ORA) and mid cap Calpine Corporation (NYSE: CPN). First of all, I should mention there are some other geothermal stocks out there like Alterra Power Corp (CVE: AXY) and Ram Power Corp (TSE: RPG) who have their primary listing on Canadian exchanges with secondary ones on the OTC – meaning they may not be a good deal for American investors or easy to invest in. Second, U.S. Geothermal Inc itself is a good geothermal proxy as its focused on developing, owning, and operating clean, sustainable electric power from geothermal energy resources and its operating geothermal power projects at Neal Hot Springs, Oregon; San Emidio, Nevada; and Raft River, Idaho plus El Ceibillo, an advanced stage, geothermal p rospect located within a 24,710 acre energy rights concession area near Guatemala City, the largest city in Central America.

10 Best Warren Buffett Stocks To Watch Right Now: Boston Scientific Corp (BSX)

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women’s Health, Neuromodulation, and Electrophysiology. In January 2011, it completed the acquisition of Intelect Medical, Inc. In January 2011, it completed the acquisition of Sadra Medical, Inc. In March 2011, the Company completed the acquisition of Atritech, Inc. In February 2011, it announced the acquisitions of S.I. Therapies and ReVascular Therapeutics, Inc. In January 2011, the Company sold its Neurovascular business to Stryker Corporation. In June 2012, the Company acquired Cameron Health, Inc. of San Clemente, California and, as a result, added to its product portfolio subcutaneous implantable cardioverter defibrillator, called the S -ICD System.

Interventional Cardiology

The Company offers coronary stent product. Coronary stents are tiny, mesh tubes used in the treatment of coronary artery disease, which are implanted in patients to prop open arteries and facilitate blood flow to and from the heart. The Company offers a two-drug platform strategy with its paclitaxel-eluting and everolimus-eluting stent system offerings, and it offers a range of stent sizes. The Company markets its next-generation internally-developed and self-manufactured PROMUS Element stent system in the United States, its Europe/Middle East/Africa (EMEA) region and certain Inter-Continental countries, including China and India. It markets the PROMUS everolimus-eluting stent system, supplied to the Company by Abbott Laboratories, in Japan. It also markets its TAXUS paclitaxel-eluting stent line, including its third-generation TAXUS Element paclitaxel-eluting stent system in the U.nited States, Japan, EMEA and certain Inter-Continental countries.

The Compa! ny markets a line of products used to treat patients with atherosclerosis, a principal cause of coronary artery obstructive disease. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA). The Company markets a family of intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels. The iLab Ultrasound Imaging System continues as its flagship console and is compatible with its line of imaging catheters. The system is designed to enhance the diagnosis and treatment of blocked vessels and heart disorders. Sadra is developing a repositionable and retrievable device for transcatheter aortic valve replacement (TAVR) to treat patients with severe aortic stenosis. The Lotus Valve System consists of a stent-mounted tiss ue valve prosthesis and catheter delivery system for guidance and placement of the valve. Atritech has developed a device designed to close the left atrial appendage in patients with atrial fibrillation who are at risk for ischemic stroke. The WATCHMAN Left Atrial Appendage Closure Technology, developed by Atritech, is the first device proven in a randomized clinical trial to offer an alternative to anticoagulant drugs, and is approved for use in CE Mark countries.

Cardiac Rhythm Management

The Company develops, manufactures and markets a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, including Implantable cardioverter defibrillator (ICD) systems used to detect and treat abnormally fast heart rhythms (tachycardia) that could result in sudden cardiac death, including implantable cardiac resynchronization therapy defibrillator (CRT-D) systems used to treat heart failure, and implantable pa cemaker systems used to manage slow or irregular heart rhyth! ms (brady! cardia), including implantable cardiac resynchronization therapy pacemaker (CRT-P) systems used to treat heart failure. Its product offerings include its COGNIS cardiac resynchronization therapy defibrillator (CRT-D), its TELIGEN ICD systems and its ALTRUA family of pacemaker systems. During 2011, it began the United States launch of its next-generation line of defibrillators, INCEPTA, ENERGEN and PUNCTUA.

Endoscopy

The Company markets a range of products to diagnose, treat and ease a variety of digestive diseases, including those affecting the esophagus, stomach, liver, pancreas, duodenum, and colon. Common disease states include esophagitis, portal hypertension, peptic ulcers as well as esophageal, biliary, pancreatic and colonic cancer. The Company offers the Radial Jaw 4 Single-Use Biopsy Forceps, which are designed to enable collection of large high-quality tissue specimens without the need to use large channel therapeutic endoscopes. Its exclu sive line of RX Biliary System devices are designed to provide greater access and control for physicians to diagnose and treat challenging conditions of the bile ducts, such as removing gallstones, opening obstructed bile ducts and obtaining biopsies in suspected tumors. The Company also markets the Spyglass Direct Visualization System for direct imaging of the pancreatico-biliary system. The Spyglass System is a single-operator cholangioscopy device that offers clinicians a direct visualization of the pancreatico-biliary system and includes supporting devices for tissue acquisition, stone management and lithotripsy. Its products also include the WallFlex family of stents, in particular, the WallFlex Biliary line and WallFlex Esophageal line; and in 2011, the Company launched its Advanix Biliary Plastic Stent System and the Expect Endoscopic Ultrasound Aspiration Needle in the United States and certain international markets. Its Resolution Clip Device is an endoscopic mechan ical clip designed to treat gastrointestinal bleeding.

T! he Company markets devices to diagnose, treat and ease pulmonary disease systems within the airway and lungs. Its products are designed to help perform biopsies, retrieve foreign bodies from the airway, open narrowings of an airway, stop internal bleeding, and ease symptoms of some types of airway cancers. Its product line includes pulmonary biopsy forceps, transbronchial aspiration needles, cytology brushes and tracheobronchial stents used to dilate narrowed airway passages or for tumor management. Asthmatx, Inc. designs, manufactures and markets a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma. The Alair Bronchial Thermoplasty System, developed by Asthmatx, has both CE Mark and Food and Drug Administration (FDA) approval and is the first device-based asthma treatment approved by the FDA.

Peripheral Interventions

The Company sells various products designed to treat patients with peripher al disease, including a line of medical devices used in percutaneous transluminal angioplasty and peripheral vascular stenting. Its peripheral product offerings include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters. In 2010 and 2011, it launched several of its products internationally, including the EPIC self-expanding nitinol stent system in certain international markets, and the Carotid WALLSTENT stent system in Japan. The Company launched three new peripheral angioplasty balloons in 2011, including its next-generation Mustang percutaneous transluminal angioplasty (PTA) balloon, its Coyote balloon catheter, a highly deliverable and ultra-low profile balloon dilatation catheter designed for a range of peripheral angioplasty procedures and its Charger PTA Balloon Catheter, a 0.035 inch percutaneous transluminal angioplasty balloon catheter designed for post-stent dilatation, as well as conventional balloon angioplasty to open blocked peripheral arteries. The Company has commenced a limited ma! rket rele! ase of its OFFROAD re-entry catheter system in certain international markets, and in February 2012, it launched its TRUEPATH intraluminal CTO device in the United States.

The Company sells products designed to treat patients with non-vascular disease. Its non-vascular suite of products include biliary stents, drainage catheters and micro-puncture sets designed to treat, diagnose and ease various forms of benign and malignant tumors. The Company continues to market its extensive line of Interventional Oncology product solutions, including the Renegade HI-FLO Fathom microcatheter and guidewire system and Interlock – 35 Fibered IDC Occlusion System for peripheral embolization. The Company’s FilterWire EZ Embolic Protection System is a filter designed to capture embolic material that may become dislodged during a procedure, which could otherwise travel into the microvasculature where it could cause a heart attack or stroke. It is commercially available in the Unit ed States, its EMEA region and certain Inter-Continental countries for multiple indications, including the treatment of disease in peripheral, coronary and carotid vessels. It is also available in the United States for the treatment of saphenous vein grafts and carotid artery stenting procedures.

Urology/Women’s Health

The Company’s Urology/Women’s Health division develops, manufactures and sells devices to treat various urological and gynecological disorders. The Company sells a variety of products designed to treat patients with urinary stone disease, stress urinary incontinence, pelvic organ prolapse and excessive uterine bleeding. The Company offers a line of stone management products, including ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons and catheters.

The Company markets a range of devices for the treatment of conditions, such as female urinary incontinence, pelvic floor reconstruc tion (rebuilding of the anatomy to its original state), and ! menorrhag! ia (excessive menstrual bleeding). It offers a breadth of mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices. The Company markets its Genesys Hydro ThermAblator (HTA) system, a next-generation endometrial ablation system designed to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia. The Genesys HTA System features a smaller and lighter console, simplified set-up requirements, and an enhanced graphic user interface and is designed to improve operating performance.

Neuromodulation

The Company within its Neuromodulation business markets the Precision Spinal Cord Stimulation (SCS) system, used for the management of chronic pain. In 2011, the Company launched its Clik Anchor for its Precision Plus SCS System, a rechargeable SCS device for chronic pain management. During 2011, it received FDA approval for and launched the Infinion 16 Percutaneous Lead, a 1 6-contact percutaneous lead. The Company also markets the Linear 3-4 and Linear 3-6 Percutaneous Leads for use with its SCS systems, which are designed to provide physicians more treatment options for their chronic pain patients. Intelect Medical, Inc. is a development-stage company developing advanced visualization and programming for the Vercise system.

Electrophysiology

The Company within its Electrophysiology business develops less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart. Included in its product offerings are radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Its products include the Blazer and Blazer Prime line of temperature ablation catheters, designed to deliver enhanced performance, responsiveness, and durability. Its cooled ablation portfolio includes the closed -loop irrigated catheter on the market, the Chilli II cooled! ablation! catheter, and the newly launched Blazer Open-Irrigated ablation catheter with a Total Tip Cooling Design.

The Company competes with Abbott Laboratories, Medtronic, Inc., St. Jude Medical, Inc. and Johnson & Johnson.

Advisors’ Opinion:

  • [By Ben Levisohn]

    The S&P 500 gained 0.3% to 1,843.80 today as Boston Scientific (BSX), Dow Chemical (DOW) and Biogen Idec (BIIB) rose. The Dow Jones Industrial Average slid 0.3% to 16,414.44.

  • [By Laura Brodbeck]

    Stocks moving in the Premarket included:

    Aflac Inc (NYSE: AFL) gained 1.59 percent in premarket trade after losing 0.19 percent on Friday. Boston Scientific Corp (NYSE: BSX) gained 1.41 percent in premarket trade after rising 3.05 percent over the past week. GameStop Corp (NYSE: GME) gained 1.27 percent in premarket trade after sliding 17.29 percent over the past 5 days. Newmont Mining Corp (NYSE: NEM) was up 0.94 percent in premarket trade after rising 3.15 percent over the past week.

    Earnings

  • [By Sy Harding]

    Boston Scientific (BSX)

    Boston Scientific develops and makes minimally invasive medical devices, including catheters, guide-wire systems, diagnostic endoscopy equipment, and the like.

  • [By Johanna Bennett]

    With its stock price already doubled in value over the last 12 months, is it time to back away from shares of Boston Scientific (BSX)? Cowen & Co. analyst Joshua Jennings doesn’t think so.

10 Best Warren Buffett Stocks To Watch Right Now: CME Group Inc.(CME)

CME Group Inc. operates the CME, CBOT, NYMEX, and COMEX regulatory exchanges worldwide. The company provides a range of products available across various asset classes, including futures and options on interest rates, equity indexes, energy, agricultural commodities, metals, foreign exchange, weather, and real estate. It offers various products that provide a means of hedging, speculation, and asset allocation relating to the risks associated with interest rate sensitive instruments, equity ownership, changes in the value of foreign currency, credit risk, and changes in the prices of commodities. CME Group owns and operates clearing house, CME Clearing, which provides clearing and settlement services for exchange-traded contracts and counter derivatives transactions; and also engages in real estate operations. Its primary trade execution facilities consist of its CME Globex electronic trading platform and open outcry trading floors, as well as privately negotiated transact ions that are cleared and settled through its clearing house. In addition, the company offers market data services comprising live quotes, delayed quotes, market reports, and historical data services, as well as involves in index services business. CME Group?s customer base includes professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, and governments. It has strategic partnerships with BM&FBOVESPA S.A., Bursa Malaysia Derivatives, Singapore Exchange Limited, Green Exchange, Dubai Mercantile Exchange, Johannesburg Stock Exchange, and Bolsa Mexicana de Valores, S.A.B. de C.V., as well as joint venture agreement with Dow Jones & Company. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group was founded in 1898 and is headquartered in Chicago, Illinois.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of Nasdaq OMX Group (NDAQ) have dropped 3% to $35.84 at 2:42 p.m. today, while IntercontinentalExchange (ICE) has fallen 2.1% to $193.69 and CME Group (CME) is off 2% at $72.53.

  • [By Lee Jackson]

    CME Group Inc. (NASDAQ: CME) exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options. CME Group brings buyers and sellers together through its Globex electronic trading platform and its trading facilities in New York and Chicago. The company also operates CME clearing, one of the world’s leading central counterparty clearing providers, which offers clearing and settlement services across asset classes for exchange-traded contracts and over-the-counter derivatives transactions. Investors are paid a solid 2.5% dividend. The consensus price target is $81.54. CME closed Wednesday at $75.71.

  • [By Marc Bastow]

    Exchange-traded and over-the-counter derivatives trader CME Group (CME) raised its quarterly dividend 4% to 47 cents per share, payable on Mar. 25 to shareholders of record as of Mar. 10.
    CME Dividend Yield: 2.47%

  • [By Anora Mahmudova]

    CME Group Inc. (CME)  shares rose slightly after the exchange operator posted fourth-quarter earnings that were below expectations.

10 Best Warren Buffett Stocks To Watch Right Now: Thinspace Technology Inc (THNS)

Thinspace Technology Inc., formerly Vanity Events Holding, Inc., incorporated on November 22, 2006, is a holding company. Utilizing their licensed trademark of America’s Cleaning Company, Vanity established a cleaning company offering residential and commercial cleaning services. In October 2012, the Company acquired fineartlender.com. In October 2012, the Company acquired additional URLS, which include Weddinggownlender.com; Suitlender.com and Bridalpartylender.com.

The Company seeks out, licenses, develops, promotes, and brings to market various consumer and commercial products. The Company markets products directly to the consumer and marketplace through one of its own properties www.ThereIsAProductForThat.com.

The Company competes with Rent the Runway, Inc., Rent-A-Center, Inc., Bag, Borrow or Steal, Inc., Aaron’s, and Gilt Groupe, Inc.

Advisors’ Opinion:

  • [By Peter Graham]

    Last Friday, small cap biotech or tech stocks Amanasu Techno Holdings Corp (OTCMKTS: ANSU), Bio Matrix Scientific Group Inc (OTCMKTS: BMSN) and Thinspace Technology Inc (OTCBB: THNS) surged 44.74%, 42.31% and 14%, respectively, with only one of these small caps appearing to be the subject of some sort of small paid promotions or investor relations campaign. Given the lack of a big pump from promoters or IR people, will these three small caps keep surging or will the tide go out again this week? Here is a quick reality check to help you decide on a trading or investing strategy:

10 Best Warren Buffett Stocks To Watch Right Now: Textura Corp (TXTR)

Textura Corporation, incorporated on September 27, 2007, is a provider of on-demand business collaboration software to the commercial construction industry. The Company’s solutions are focused on facilitating collaboration between owners/developers, general contractors and subcontractors. The Company offers PlanSwift, a take-off and estimating solution used in preparing construction bids, and Contractor Default Claims Management, which supports the process of documenting a subcontractor default insurance claim. Each of its collaboration solutions was designed from inception as a software-as-a-service (SaaS) solution with on-demand architecture. The Company collaboration solutions each use a single code base and it do not customize its solutions for any of the Company’s clients. In December 2013, Textura Corp closed its acquisition of LATISTA Technologies Inc, the provider of mobile-enabled solutions for construction project collaboration.

The Company’s c ollaboration solutions offer functionality, data sharing and exchange capabilities, and workflow tools that support several business processes at various stages of the construction project lifecycle, which include Construction Payment Management (CPM) enables the generation, collection, review and routing of invoices and the necessary supporting documentation and legal documents, and initiation of payment of invoices; Submittal Exchange enables the collection, review and routing of project documents; GradeBeam supports the process of obtaining construction bids, including identifying potential bidders, issuing invitations-to-bid and tracking bidding intent; Pre-Qualification Management (PQM) supports contractor risk assessment and qualification, and Greengrade facilitates the management of environmental certification processes. The Company’s on-demand business collaboration software solutions address the several challenges associated with the traditional paper-based and pe rsonnel-intensive manual approaches or with technology solut! ions not designed for collaborative processes, and support many of the trends occurring within the commercial construction industry.

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Textura Corp. (NYSE: TXTR) was reiterated as Outperform along with a $50 price target at Credit Suisse. The firm said that a negative report from Citron on the company last week that knocked about 20% of its value off has created as buying opportunity. Credit Suisse believes the report is untrue. It said the report was full of profanity and that it sees no merits to any of the work, with the report alluding to incorrect innuendos and false assumptions that suggested management misled investors. After shares saw a more than a 5% gain to $29.54 on Friday, the post-IPO range is $19.68 to $47.25.

  • [By Jake L’Ecuyer]

    Equities Trading DOWN
    Shares of Twitter (NYSE: TWTR) were down 11.59 percent to $64.92 after Macquarie downgraded the stock from Neutral to Underperform. Textura (NYSE: TXTR) tumbled 5.24 percent to $29.66. Textura shares tumbled 17.06 percent yesterday after Citron Research issued a scathing report on the company midway through the morning Thursday.

  • [By Jake L’Ecuyer]

    Textura (NYSE: TXTR) tumbled 6.15 percent to $29.38. Textura shares tumbled 17.06 percent yesterday after Citron Research issued a scathing report on the company midway through the morning Thursday.